SPRINGFIELD, Mass. (WWLP) - Baystate Medical Center is researching a new drug that could benefit children with autism.
Doctors are behind a new clinical research program called the "Connect Me-91study". The hope is that this latest drug could treat some of the core symptoms of common behavioral disorders, like autism.
The Centers for Disease Control and Prevention reports that 1 in 88 children has an autism spectrum disorder; and 1 in 50 U.S. schoolchildren has an autism spectrum disorder. Baystate doctors say as the disorder becomes more prevalent in society, it reinforces how important it is for parents to get their children tested as early as possible.
Bruce Waslick, a child psychiatrist at Baystate, told 22News, "There are some kids who actually do quite well getting a full comprehensive intervention program and educational supports; other kids struggle by symptoms and are disabled by the disorder. It's a wide range of outcomes but autism doesn't imply you can't live a full and normal life."
If your child is 6 to 12 years old, he or she may be eligible to participate in the ConnectMe clinical research program. It includes 3 clinical research studies and it will also evaluate the safety and effectiveness of this new, investigational drug. For more information, call (413) 794-1136.